S0322, Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

This study has been terminated.

( Poor accrual )

Study NCT00068497 Information provided by Southwest Oncology Group

First Received: September 10, 2003 Last Updated: August 24, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)